Human Resources Manager

DTx Pharma is seeking an enthusiastic and highly motivated individual to manage our human resources activities. We are in search of a Human Resources Manager with excellent communication skills, who will be responsible for coordinating all administrative activities related to an organization’s personnel. This candidate for this managerial position must have previous experience in the human resources field with demonstrated competence in organizing and executing strategic plans. This position operates within a fast-paced interdisciplinary environment, so flexibility and organizational skills are required.  The successful candidate will be responsible for activities such as:

  • Manage the staffing process, including recruiting, coordinating interviews, and onboarding
  • Ensure job descriptions are up to date and compliant with all local, state and federal regulations
  • Develop training materials and performance management programs to help ensure employees understand their job responsibilities
  • Administer various employee benefits programs including group medical/vision, dental, life and supplemental insurances
  • Support Accounting with payroll activities
  • Work with Executive Management to develop and maintain salary bands for all job positions based on market research and pay surveys
  • In conjunction with Executive Management, investigate employee issues and conflicts and support a resolution
  • Ability to create a culture of diversity, inclusivity, collaboration and teamwork
  • Ensure the organization’s compliance with local, state and federal regulations

Qualifications & Experience:

  • Bachelor’s degree 
  • 3-5 years’ experience in human resources management
  • Excellent written and verbal communication skills
  • Excellent computer skills (Excel, Word, PowerPoint)
  • Ability to work with a diverse team in a dynamic environment

Company Overview:

DTx Pharma, Inc. is a privately held biotechnology company based in San Diego, CA creating novel RNA-based therapeutics to treat the genetic drivers of disease. The company’s proprietary delivery technology platform utilizes fatty acids as targeting ligands to enable the delivery of oligonucleotide therapies to tissues and cell types throughout the body. In preclinical studies, DTx has demonstrated cellular uptake and broad activity of oligonucleotides in the retina, muscle, heart, neurons, T cells, and other specialized cell types. To advance the FALCON platform toward and into clinical development, DTx has raised more than $100M in combined investment from several of the world’s leading healthcare investors including RA Capital Management and Access Biotechnology, pharmaceutical companies such as Eli Lilly and Company, the National Institute of Health (NIH), and research foundations such as the CMT Research Foundation (CMTRF). To learn more about DTx Pharma, please visit www.dtxpharma.com and follow DTx on LinkedIn and Twitter @DTxPharma.

Contact us